Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 8
1964 20
1965 9
1966 11
1967 18
1968 30
1969 30
1970 35
1971 31
1972 36
1973 37
1974 55
1975 39
1976 45
1977 29
1978 47
1979 46
1980 65
1981 32
1982 45
1983 57
1984 49
1985 43
1986 51
1987 55
1988 87
1989 99
1990 108
1991 101
1992 102
1993 162
1994 134
1995 101
1996 111
1997 136
1998 117
1999 129
2000 152
2001 123
2002 106
2003 133
2004 129
2005 143
2006 140
2007 119
2008 162
2009 143
2010 171
2011 180
2012 160
2013 196
2014 203
2015 167
2016 172
2017 168
2018 225
2019 196
2020 177
2021 223
2022 233
2023 142
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5,908 results

Results by year

Filters applied: . Clear all
Page 1
Paraneoplastic syndromes: an approach to diagnosis and treatment.
Pelosof LC, Gerber DE. Pelosof LC, et al. Mayo Clin Proc. 2010 Sep;85(9):838-54. doi: 10.4065/mcp.2010.0099. Mayo Clin Proc. 2010. PMID: 20810794 Free PMC article. Review.
Treatments include addressing the underlying malignancy, immunosuppression (for neurologic, dermatologic, and rheumatologic paraneoplastic syndromes), and correction of electrolyte and hormonal derangements (for endocrine paraneoplastic syndromes). Thi …
Treatments include addressing the underlying malignancy, immunosuppression (for neurologic, dermatologic, and rheumatologic paraneoplasti …
Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis.
Okamoto A, Watanabe T, Kamata K, Minaga K, Kudo M. Okamoto A, et al. Intern Med. 2019 Jun 1;58(11):1533-1539. doi: 10.2169/internalmedicine.2210-18. Epub 2019 Feb 1. Intern Med. 2019. PMID: 30713326 Free PMC article. Review.
Moreover, the simultaneous occurrence of cancer and AIP in many patients has led to the establishment of an attractive concept that AIP might sometimes arise from co-existing cancers as a paraneoplastic syndrome....
Moreover, the simultaneous occurrence of cancer and AIP in many patients has led to the establishment of an attractive concept that AIP migh …
Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis.
Didona D, Fania L, Didona B, Eming R, Hertl M, Di Zenzo G. Didona D, et al. Int J Mol Sci. 2020 Mar 21;21(6):2178. doi: 10.3390/ijms21062178. Int J Mol Sci. 2020. PMID: 32245283 Free PMC article. Review.
Skin manifestations of systemic disease and malignancy are extremely polymorphous. Clinicians should be familiarized with paraneoplastic dermatoses in order to perform an early diagnosis of the underlying neoplasm. Lack of familiarity with cutaneous clues of internal malig …
Skin manifestations of systemic disease and malignancy are extremely polymorphous. Clinicians should be familiarized with paraneoplastic …
Paraneoplastic neurological syndromes.
Graus F, Dalmau J. Graus F, et al. Curr Opin Neurol. 2012 Dec;25(6):795-801. doi: 10.1097/WCO.0b013e328359da15. Curr Opin Neurol. 2012. PMID: 23041955 Free PMC article. Review.
PURPOSE OF REVIEW: This review describes relevant advances in paraneoplastic neurological syndromes (PNS) with emphasis on particular syndromes and the impact of antibodies against surface antigens in their management. ...SUMMARY: The number of antibodies rel …
PURPOSE OF REVIEW: This review describes relevant advances in paraneoplastic neurological syndromes (PNS) with emphasis on par …
Cutaneous paraneoplastic syndromes.
Wick MR, Patterson JW. Wick MR, et al. Semin Diagn Pathol. 2019 Jul;36(4):211-228. doi: 10.1053/j.semdp.2019.01.001. Epub 2019 Jan 31. Semin Diagn Pathol. 2019. PMID: 30736994 Review.
Yet another group of lesions can be regarded as associated markers of the malignant process, and, as such, are termed "paraneoplastic." This review considers the latter collection of conditions, grouping them by the generic type of malignancy that is usually linked to the …
Yet another group of lesions can be regarded as associated markers of the malignant process, and, as such, are termed "paraneoplastic …
Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.
Binks S, Uy C, Honnorat J, Irani SR. Binks S, et al. Pract Neurol. 2022 Feb;22(1):19-31. doi: 10.1136/practneurol-2021-003073. Epub 2021 Sep 11. Pract Neurol. 2022. PMID: 34510016 Review.
Paraneoplastic neurological syndromes (PNS) are the immune-mediated effects of a remote cancer and are characterised by an autoantibody response against antigens expressed by the tumour. ...There is a variable response to immunotherapies and the clinical syndrome …
Paraneoplastic neurological syndromes (PNS) are the immune-mediated effects of a remote cancer and are characterised by an aut …
Stiff-person syndrome: insights into a complex autoimmune disorder.
Baizabal-Carvallo JF, Jankovic J. Baizabal-Carvallo JF, et al. J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):840-8. doi: 10.1136/jnnp-2014-309201. Epub 2014 Dec 15. J Neurol Neurosurg Psychiatry. 2015. PMID: 25511790 Review.
Stiff-person syndrome (SPS) is characterised by progressive rigidity and muscle spasms affecting the axial and limb muscles. ...Antibodies directed against GABA(A) receptor-associated protein, and the glycine-alpha1 receptor can also be observed. Paraneoplastic SPS …
Stiff-person syndrome (SPS) is characterised by progressive rigidity and muscle spasms affecting the axial and limb muscles. ...Antib …
Management of non-islet-cell tumor hypoglycemia: a clinical review.
Bodnar TW, Acevedo MJ, Pietropaolo M. Bodnar TW, et al. J Clin Endocrinol Metab. 2014 Mar;99(3):713-22. doi: 10.1210/jc.2013-3382. Epub 2013 Dec 11. J Clin Endocrinol Metab. 2014. PMID: 24423303 Free PMC article. Review.
CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) is a rare but serious paraneoplastic syndrome in which a tumor secretes high molecular weight IGF-II, causing hypoglycemia. ...EVIDENCE ACQUISITION: PubMed searches were conducted for: "non-islet-cell tumor hypoglyc …
CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) is a rare but serious paraneoplastic syndrome in which a tumor secretes hig …
Cancer Cachexia: More Than Skeletal Muscle Wasting.
Schmidt SF, Rohm M, Herzig S, Berriel Diaz M. Schmidt SF, et al. Trends Cancer. 2018 Dec;4(12):849-860. doi: 10.1016/j.trecan.2018.10.001. Epub 2018 Oct 24. Trends Cancer. 2018. PMID: 30470306 Review.
Here, we describe recent developments elucidating the roles of different tissues as well as tissue crosstalk in this wasting syndrome, including potential links to other cancer-associated morbidities. ...
Here, we describe recent developments elucidating the roles of different tissues as well as tissue crosstalk in this wasting syndrome …
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S. Jan de Beur SM, et al. J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13. J Intern Med. 2023. PMID: 36511653 Free PMC article. Review.
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth factor 23 (FGF23). ...
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth …
5,908 results